05.23.25 -- Planning For Perseverance

On the Business of Biotech, Alltrna CEO Michelle Werner discusses how engineered tRNA therapies could treat thousands of rare genetic diseases. She shares how her child's diagnosis influenced her drug development approach, explores Alltrna’s use of AI and machine learning, and outlines plans for basket trials. Hosted by Ben Comer with guest co-host Anna Rose Welch. Brought to you by Avantor.

Explore a proposed digital ecosystem that would balance rigorous validation with the urgent need for accessible mental health solutions, transforming the landscape into a resource for global well-being.

Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced oncology CRO crucial for overcoming hurdles and ensuring trial success.

Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.

By analyzing patient data sets, AI enhances predictive analytics, supports real-time patient alerts, and strengthens continuous monitoring — improving the effectiveness of clinical trial oversight.